The document outlines how Labcorp supports precision medicine development across the full lifecycle—from discovery to clinical trials and commercialization—by providing data-driven insights, biomarker strategies, and global testing capabilities. It emphasizes the critical role of biomarkers and companion diagnostics (CDx) in improving trial success, targeting the right patients, and accelerating regulatory approval. Labcorp offers end-to-end services including biomarker discovery, assay development, clinical trial management, regulatory support, and commercialization, leveraging large-scale datasets and global infrastructure. By integrating therapeutic and diagnostic development in parallel, Labcorp helps biopharma companies reduce risk, improve efficiency, and bring targeted therapies to market faster while expanding patient access.

Join for free to read